Member Detail - DF/HCC

Dr. Michael Cheng

Claim this profile

Dana Farber Cancer Institute

Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
6 reported clinical trials
17 drugs studied

Area of expertise

1Lung Cancer
Michael Cheng has run 5 trials for Lung Cancer. Some of their research focus areas include:
Stage III
Stage IV
Stage II
2Non-Small Cell Lung Cancer
Michael Cheng has run 2 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Stage III
Stage IV
Stage II

Affiliated Hospitals

Image of trial facility.
Dana Farber Cancer Institute
Image of trial facility.
Brigham And Women's Hospital

Clinical Trials Michael Cheng is currently running

Image of trial facility.

ZEN003694 + Chemotherapy

for Cancer

This phase I/II trial tests the safety, side effects, and best dose of a new combination of drugs, ZEN003694, cisplatin, and etoposide in treating patients with NUT carcinoma (phase I), and identifies whether this combination therapy works to shrink tumor in these patients (phase II). Another purpose of this study is to see whether there are any changes in patient's tumor or blood characteristics (e.g. genes, molecules, etc.) due to combination therapy. ZEN003694 inhibits the production of certain growth-promoting proteins and may prevent proliferation of tumor cells that use those proteins for their growth. Chemotherapy drugs, such as etoposide and cisplatin, work by stopping or slowing the growth of cancer cells. Combination therapy with ZEN003694, etoposide and cisplatin may be effective in treating patients with NUT carcinoma.
Recruiting1 award Phase 1 & 2

More about Michael Cheng

Clinical Trial Related5 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Michael Cheng has experience with
  • Carboplatin
  • Pembrolizumab
  • Cisplatin
  • Etoposide
  • ZEN003694
  • InVision
Breakdown of trials Michael Cheng has run
Lung Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
NUT Carcinoma
NUT Midline Carcinoma

Other Doctors you might be interested in

Sapna Syngal, MDDana Farber Cancer Center, Harvard University
Gregory Cote, MDMassachusetts General Hospital
James M. ClearyDana Farber Cancer Institute

Frequently asked questions

Do I need insurance to participate in a trial?
What does Michael Cheng specialize in?
Is Michael Cheng currently recruiting for clinical trials?
Are there any treatments that Michael Cheng has studied deeply?
What is the best way to schedule an appointment with Michael Cheng?
What is the office address of Michael Cheng?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security